Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

Apr 26, 2023

SELL
$107.32 - $113.5 $33.3 Million - $35.2 Million
-310,009 Reduced 59.2%
213,669 $23.3 Million
Q4 2022

Feb 09, 2023

SELL
$62.39 - $113.8 $76 Million - $139 Million
-1,217,432 Reduced 69.92%
523,678 $59.6 Million
Q3 2022

Nov 01, 2022

BUY
$58.92 - $84.67 $24.8 Million - $35.6 Million
420,629 Added 31.85%
1,741,110 $108 Million
Q2 2022

Aug 02, 2022

SELL
$79.4 - $116.36 $5.74 Million - $8.41 Million
-72,313 Reduced 5.19%
1,320,481 $105 Million
Q1 2022

May 11, 2022

BUY
$86.42 - $109.81 $3.66 Million - $4.66 Million
42,399 Added 3.14%
1,392,794 $147 Million
Q4 2021

Feb 08, 2022

BUY
$98.56 - $119.91 $38.7 Million - $47.1 Million
392,451 Added 40.97%
1,350,395 $146 Million
Q3 2021

Nov 09, 2021

BUY
$91.91 - $110.37 $1.13 Million - $1.36 Million
12,339 Added 1.3%
957,944 $105 Million
Q2 2021

Aug 12, 2021

BUY
$86.24 - $95.92 $2.12 Million - $2.36 Million
24,579 Added 2.67%
945,605 $88.5 Million
Q1 2021

May 11, 2021

BUY
$71.83 - $95.48 $5.19 Million - $6.9 Million
72,279 Added 8.52%
921,026 $84.8 Million
Q4 2020

Feb 05, 2021

BUY
$67.0 - $84.39 $1.53 Million - $1.92 Million
22,794 Added 2.76%
848,747 $62.1 Million
Q3 2020

Nov 04, 2020

SELL
$55.23 - $79.93 $16.6 Million - $24.1 Million
-301,441 Reduced 26.74%
825,953 $64.2 Million
Q2 2020

Aug 06, 2020

SELL
$30.2 - $56.98 $26.2 Million - $49.4 Million
-867,747 Reduced 43.49%
1,127,394 $62.7 Million
Q1 2020

May 06, 2020

BUY
$24.87 - $38.56 $939,762 - $1.46 Million
37,787 Added 1.93%
1,995,141 $59.1 Million
Q4 2019

Feb 07, 2020

SELL
$25.43 - $36.67 $15 Million - $21.6 Million
-589,683 Reduced 23.15%
1,957,354 $70.9 Million
Q3 2019

Nov 08, 2019

BUY
$23.0 - $27.97 $4.06 Million - $4.93 Million
176,419 Added 7.44%
2,547,037 $69.4 Million
Q2 2019

Aug 09, 2019

BUY
$22.81 - $28.48 $54.1 Million - $67.5 Million
2,370,618 New
2,370,618 $57 Million

Others Institutions Holding HZNP

About Horizon Therapeutics Public Ltd Co


  • Ticker HZNP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 230,384,000
  • Description
  • Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...
More about HZNP
Track This Portfolio

Track Jennison Associates LLC Portfolio

Follow Jennison Associates LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jennison Associates LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jennison Associates LLC with notifications on news.